RP Bio Statistics

Total Valuation

RP Bio has a market cap or net worth of KRW 53.30 billion. The enterprise value is 61.28 billion.

Market Cap	53.30B
Enterprise Value	61.28B

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

RP Bio has 8.67 million shares outstanding. The number of shares has decreased by -21.14% in one year.

Current Share Class	8.67M
Shares Outstanding	8.67M
Shares Change (YoY)	-21.14%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	61.75%
Owned by Institutions (%)	0.10%
Float	3.31M

Valuation Ratios

The trailing PE ratio is 40.72.

PE Ratio	40.72
Forward PE	n/a
PS Ratio	0.42
PB Ratio	0.51
P/TBV Ratio	0.52
P/FCF Ratio	5.81
P/OCF Ratio	3.29
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 7.48, with an EV/FCF ratio of 6.68.

EV / Earnings	46.89
EV / Sales	0.49
EV / EBITDA	7.48
EV / EBIT	44.63
EV / FCF	6.68

Financial Position

The company has a current ratio of 1.22, with a Debt / Equity ratio of 0.25.

Current Ratio	1.22
Quick Ratio	0.73
Debt / Equity	0.25
Debt / EBITDA	3.18
Debt / FCF	2.84
Interest Coverage	1.16

Financial Efficiency

Return on equity (ROE) is 1.27% and return on invested capital (ROIC) is 0.64%.

Return on Equity (ROE)	1.27%
Return on Assets (ROA)	0.53%
Return on Invested Capital (ROIC)	0.64%
Return on Capital Employed (ROCE)	1.25%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.77
Inventory Turnover	4.19

Taxes

Income Tax	-318.76M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -17.51% in the last 52 weeks. The beta is 0.54, so RP Bio's price volatility has been lower than the market average.

Beta (5Y)	0.54
52-Week Price Change	-17.51%
50-Day Moving Average	5,906.00
200-Day Moving Average	5,561.28
Relative Strength Index (RSI)	63.12
Average Volume (20 Days)	11,751

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, RP Bio had revenue of KRW 125.47 billion and earned 1.31 billion in profits. Earnings per share was 151.04.

Revenue	125.47B
Gross Profit	9.27B
Operating Income	1.37B
Pretax Income	988.30M
Net Income	1.31B
EBITDA	8.20B
EBIT	1.37B
Earnings Per Share (EPS)	151.04

Full Income Statement

Balance Sheet

The company has 18.05 billion in cash and 26.04 billion in debt, giving a net cash position of -7.99 billion or -921.49 per share.

Cash & Cash Equivalents	18.05B
Total Debt	26.04B
Net Cash	-7.99B
Net Cash Per Share	-921.49
Equity (Book Value)	103.56B
Book Value Per Share	11,973.05
Working Capital	11.93B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 16.20 billion and capital expenditures -7.02 billion, giving a free cash flow of 9.18 billion.

Operating Cash Flow	16.20B
Capital Expenditures	-7.02B
Free Cash Flow	9.18B
FCF Per Share	1,058.75

Full Cash Flow Statement

Margins

Gross margin is 7.39%, with operating and profit margins of 1.09% and 1.04%.

Gross Margin	7.39%
Operating Margin	1.09%
Pretax Margin	0.79%
Profit Margin	1.04%
EBITDA Margin	6.53%
EBIT Margin	1.09%
FCF Margin	7.31%

Dividends & Yields

RP Bio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	33.09%
Buyback Yield	21.14%
Shareholder Yield	n/a
Earnings Yield	2.45%
FCF Yield	17.22%

Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

RP Bio has an Altman Z-Score of 1.76 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.76
Piotroski F-Score	5